After 24 months of treatment, the serum ghrelin level and the body mass index of children with CH decreased significantly compared with those before treatment, and the difference was statistically significant (P < 0.05) (see Figure 3 for details). This evidence concerns the gene GHRL and cyclic hematopoiesis.